Affiliation:
1. Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten (IPEK), Ludwig-Maximilians-Universität (LMU), München, Germany
Abstract
Endothelial dysfunctions together with a dysregulated immune response and lipid accumulation are important confounding factors in the onset and chronic development of atherosclerosis. Recently, a large body of data has emerged on the sequential involvement of different immune cell types, including monocytes, in the pathology of this disease. In this condensed review, we aim to highlight some of the recent basic research and clinical findings on monocyte subsets published since our joint European Society of Cardiology consensus document, and re-evaluate their potential relevance as surrogate biomarkers in coronary artery disease.
Funder
Deutsche Forschungsgemeinschaft
August-Lenz-Stiftung
Reference32 articles.
1. Atherosclerosis: current pathogenesis and therapeutic options;C Weber;Nat Med,2011
2. Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups “Atherosclerosis & Vascular Biology” and “Thrombosis”;C Weber;Thromb Haemost,2016
3. Blood monocytes: development, heterogeneity, and relationship with dendritic cells;C Auffray;Annu Rev Immunol,2009
4. Monocyte recruitment during infection and inflammation;C Shi;Nat Rev Immunol,2011
5. Monocyte heterogeneity in cardiovascular disease;A V Ruder;Cardiovasc Res,2023